BIO CEO & Investor Conference

February 8-9, 2021・New York Marriott Marquis

Partnering Companies

Below is a representative list of partnering companies for the 2020 CEO & Investor Conference:

20/20 GeneSystems
3E Bioventures
3i Fund
A C Binder Corp
A2A Pharmaceuticals
Ab Studio
AbbVie
Abingworth Management
Accelmed Partners
Aceras Partners
Achillion Pharmaceuticals
Acorn Bioventures
ACT Capital Management
Actinium
Acuitas Capital Family Office
Aditum Bio
Adjuvant Capital
Admirx
Aegis Capital
Aetion
Affinity Asset Advisors
AFUND
Ai Cure Technologies
AIG
AIMM Therapeutics
Aisling Capital
AiVita Biomedical
Aleph Capital
Alexandria Venture Investments
Alignment Ventures
Allele Capital Partners
Alliance for Aging Research
Alliance for Cancer Gene Therapy
Alliance for Regenerative Medicine
Alliance Global Partners
Alnitak Capital
Alnylam Pharmaceuticals
Alpha Cancer Technologies
Alpine Equity Advisors
Alpine Immune Sciences
ALPS
Altimmune
ALTuCELL
Alveo Technologies
American Gene Technologies International
Amnicell
Amplitude Ventures
Amplyx Pharmaceuticals
Amygdala Neurosciences
Anavex Life Sciences
Andreessen Horowitz
AnGes
AnHeart Therapeutics (Hangzhou)
Anima Biotech
Anson Funds
Aon Risk Solutions
Apex-Brasil - Brazilian Trade and Investment Promotion Agency
Aprinoia Therapeutics
Aptorum Group
Aptose Biosciences
Aracari Biosciences
Aracle Capital
Arch Biopartners
Arch Venture Partners
Arcturus Therapeutics
Arena Pharmaceuticals
Aristar Capital
Arix Bioscience
ARJUNA Therapeutics
Armistice Capital
Aro Biotherapeutics
Arsenal Capital Partners
Aruvant Sciences
Arviat Pharmaceuticals
Ascendia Pharmaceuticals
Ascendiant Capital Markets
Ashford Capital Management
Ashvattha Therapeutics
Asimov
Aspire Capital
Asset Management Ventures
Astellas Pharma US
Astellas Venture Management
Astute Capital
ATEM Capital
Athena Bio Ventures
Atheneos Ventures
Atossa Genetics
Atreca
aTyr Pharma
AUGC
Aurora Capitals
Avalere Health
Avenue Therapeutics
Avixa Capital
Ayrton Capital
Azitra
AZTherapies
Baidu
Baird
Bank of America Merrill Lynch
Barclays
Barer & Son Capital
Bathala Capital
Beacon Capital
Beacon Pharmaceutical
Bellerophon Therapeutics
Berenberg Capital Markets
Berlin Partner für Wirtschaft und Technologie GmbH
Bifrost Capital
Bigger Capital Fund
BIMA Capital
Bioadvance-The Biotech Greenhouse Corp of Southeastern PA
Bioasis Technologies
BioCentury
Biocept
Biocoast Capital
Bioharmony Therapeutics
BioIDEA
BioIdeations
Bioincept
Bioindustry Association (BIA)
BioInnovation Capital
BioLineRx
BioMarker Strategies
Biondo Investment Advisors
Bios Partners
BioSense Global
Biotech Alliances International
Biotech Investment Group
BioVersys AG
BioXcel Therapeutics
Birch Therapeutics
Black Diamond Advisors
Blaise Group International
Bloom Capital
Bloomberg Intelligence
Blue Rock Capital Advisors
Bohe Angel Fund
Bojian Capital
Boundless Bio
Brace Pharma Capital
BrainStorm Cell Therapeutics
Breakthrough Genomics
Brex
Bridge Bank
Bristol-Myers Squibb Company
Brock Capital Group
Brookline Capital Markets
Bryan, Garnier & Co.
BTIG
Buckman Buckman & Reid
Button Capital
BVCF
BW Therapeutics
Caladrius Biosciences
California Life Sciences Association
Canaccord Genuity
Canary Health Tech
Cancer Prevention Pharmaceuticals
Cantor Fitzgerald & Company
Capital Family Office
Cardinal Health
Catalyst Pharmaceuticals
Catalyze
Cato BioVentures
Cavalry Pharma
Caxton Alternative Management
C-Bridge Capital
Cedrus Group
Celavie Biosciences
Cell Care Therapeutics
Celmatix
CEL-SCI Corporation
Center for Talent Innovation
Centerview Partners
Centrecourt Asset Management
Cerevance
Cernostics
CerSci Therapeutics
Chaperone Investment
Chardan Capital Markets
Charlestown Capital
Chartwell
Checkmate Capital
ChemioCare
China Grand Enterprises
Chronon Capital
Chubb
Church Pension Fund
Citi
CJ Seligman & Co.
Clarivate Analytics
Clearside Biomedical
CLI Ventures
Clinical Network Services (Cns)
CODA Biotherapeutics
CohBar
Collage Partners
Concarlo Holdings
Consulate General of Lithuania
Correlia Biosystems
Cowen Healthcare Investments
Cowin Venture
CreActive Health
Crescent Capital Ventures
Cristal Therapeutics
Crosswave Management
CRV
CSC Leasing
CTI Capital Gestion
CTTQ Pharmaceutical Group
CV6 Therapeutics
CyberMed Holdings
Cybrexa Therapeutics
Cyclacel Pharmaceuticals
CytoDel
Cytonus Therapeutics
Cytovia Therapeutics
Da Volterra
Dabar Investment Associates
Daré Bioscience
DB Capital
Deca Ventures
Decheng Capital
DeckTherapeutics
Decoy Biosystems
DeepBiome Therapeutics
Deerfield Management Company
DEFTA Partners
Delaware Innovation Space
DelMar Pharmaceuticals
Delos Advisors
Deltec Bank
Delwar Capital Management
DepYmed
Deutsche Bank
DHVC
District 2 Capital
Diverse Biotech
Doha Institute For Graduate Studies
Douglas C. Lane & Associates
Drusolv Therapeutics
DTB Capital Management
Dyadic International
Dynamk Capital
Dyve Biosciences
E Physician's Office
E Squared Capital Management
Eagle Pharmaceuticals
Easton Capital
Edgewood Management
eFFECTOR Therapeutics
EG Capital Advisors
EGB Ventures
Eleusis
Eight Bridges
Eli Lilly and Company
Eloxx Pharmaceuticals
Emerald Bioscience
ENB Therapeutics
Encore Advisory
Enesi Pharma
Engage Therapeutics
Engrail Therapeutics
Ensconce Capital
Entrinsic Health
Envisagenics
EpicentRx
EpimAb Biotherapeutics
EpiVax Oncology
Equillium
Esousa Holdings
etectRx
E-Therapeutics
ETP Global Fund
Eupraxia Pharmaceuticals
Evaluate
Evexia
EVOLUTION Life Science Partners
Evonetix
EVQLV
Executive Forum Angels
Exome Asset Management
Experient
EyeGate Pharmaceuticals
Fannin Innovation Studio
FC Capital
First Island Capital
First Seafront Fund Management
First Wave
FMG Ventures
Fortress Biotech
Fountain Healthcare Partners
Foxhill Asset Management
Franklin Global Partners
Frigate Capital Management
FSD Pharma
Fujifilm Diosynth Biotechnologies
GS4 Capital
Gagnon Securities
Gain Therapeutics
GBA Group Pharma
Gedeon Richter
Geistlich Pharma North America
Gel4Med
Genfit SA
Genisphere
Georgia, USA
Gero PTE
Global Blood Therapeutics
Global Corporate Finance
Global Founders Capital
Glycomine
Glycostem Therapeutics
Glysantis
Gnomegen
Golden Eagle Capital Advisors
Goldilocks Therapeutics
Goldman Sachs
Goldwater Asset Management
Good Health Capital
Greater Zurich Area Ag
GreenSky Capital
Greenwich LifeSciences
Grey Sky Venture Partners
Gryphon Partners
Guggenheim
H.C. Wainwright & Company
H.I.G. BioHealth Partners
H.I.G. Capital Management
Halozyme Therapeutics
Hannol Ventures
Harbin Pharmaceutial Group
Harpoon Therapeutics
Harvard Investors Group
Headland Strategy Group
Health Innovative Technology Corporation
HealthCare Royalty Partners
HEDA Ventures
Helicase Venture
Helios Capital
Hercules Capital
Hibiscus Bioventures
HighCape Capital
Highland Capital Management
Histogen
Hitech Health
Hollenbeck Pharmaceuticals
Horizon Technology Finance
Hudson East Capital
Hudson Square Capital
Hyperplane VC
Ichor Biologics
ICR
IDA Ireland
Ilya Pharma
Immunis.AI
ImmunoMet Therapeutics
Immunovant
ImmunSYS
Impel NeuroPharma
IMV
Inbio Ventures
InCarda Therapeutics
Incysus Therapeutics
Inflection Biosciences
Informa
Ingenio Therapeutics, Inc. / Mayewell Capital
InMed Pharmaceuticals
INmune Bio
Innovent Biologics
Integrium
Intercept Pharmaceuticals
InteRNA Technologies
Inthera Bioscience
inThought Research
Intract Pharma
Intuitive
Inukshuk Capital
iQure Pharma
Ironshore Pharmaceutical & Development
ISAR Capital Management
J.P. Morgan
J.W. Childs Associates
Janney Montgomery Scott
Janssen R&D
Jefferies
Jefferson Pharmaceuticals
JH Darbie & Co.
JHL Biotech
Jiangsu Hengrui Medicine Co.
Jina Ventures
JM Cohen & Co.
JMP Securities
Johnson & Johnson
Johnston Associates
J.P. Morgan

K2 HealthVentures
Kalka Fund
Katena Oncology
Keynote Coaching
Keystone Capital Partners
Kineta
Kintai Therapeutics
Kirrhos Pharmaceuticals
Kisoji Biotechnology
Kissei America
Kitov Pharma
KKR
Knoll Capital Management
Knott Partners
Korea Drug Development Fund
Krensavage Asset Management
Kymeris
Ladenburg Thalmann
Laidlaw Venture Partners
Landmark Angels
Landos Biopharma
Lauren Sciences
LaVoieHealthScience
Leading BioSciences
Leading Business Ventures
Leap Therapeutics
Lexington Capital Management
Libera Bio
Life Science Leader
Life Sciences Greenhouse of Central PA
LifeNet Health
LifeScience EquityPartners
LifeTech Capital
Lilly Asia Ventures
Liminal BioSciences
Lincoln Park Capital
Lion Hunter Capital
Lions Bay Capital
Lipella Pharmaceuticals
Livingston
Locust Walk
Loki Therapeutics
Longitude Capital
Lowell Therapeutics
LSWorks
LumeBio
Lumira Ventures
Lyfe Capital
MacDougall Biomedical Communications
Madison Global Partners
Madison Square Capital
Madryn Asset Management
MAIA Biotechnology
Marcum
Massive Bio
Matricelf
MaveriX Oncology
MaxCyte
Maxim Group
MaxWell Biosciences
MAZ Capital Advisors
MB Dislocation Opportunity Fund
MD Anderson Cancer Center
Med Pro Investors
MediSieve Limited
MedPro Investors
Merck KGaA
Merlin Nexus
MetVital
Microba
Mid Atlantic Bio Angels
Millennium Management
MimiVax
Mission Pharmacal
MIT Alumni Angels of Northern California
Mitsui & Co. Global Investment Inc.
Mizuho Corporate Bank
Mizuho Securities
Mizuho Securities USA
Modra Pharmaceuticals
Mogrify Limited
Molecular Theranostics
Moose Hill Asset Management
Morgan Capital
Morrison & Foerster
Mount Sinai School of Medicine
Mountain Brook Capital
Mucpharm
Murray Capital Group
Muscular Dystrophy Association (MDA)
MV Corp Services
MyoKardia
Nascent Biotech
National Heart, Lung, and Blood Institute
National Holdings Corporation
National Institutes of Health
NauVista Capital Management
Navigen Pharmaceuticals
NB Health Laboratory Co.
NCL Technology Ventures
NDA Group
NDFOS
Needham & Co.
Nektar Therapeutics
Network 1 Financial Securities
Neumentum
Neurogenesis
Neurolign Technologies
Neuroptika
NeuroRx
Neurotrope
New Enterprise Associates (NEA)
New Orleans Business Alliance
New York Angels
New York BIO
Newburgh Bay Capital
NewLink Genetics
Newron Pharmaceuticals
NGM Biopharmaceutical
NGN Capital
NGT BioPharma Consultants
Nikon Instruments
Nirogyone Therapeutics
Noble Equity Fund
Northlea Partners
Notogen
Novadip Biosciences
Novatio Ventures
Novice Therapeutics
Novo Ventures (US)
Now Biopharma
NSIP
NYC Builds Bio+
NYCMedtech/Perselson
NYU Innovation Venture Fund
Oasis Capital
Oberland Capital Management
Oligomerix
OliPass
Omega Funds
Oncodesign
Oncolyze
Onconova Therapeutics
OncoSec Immunotherapies
ONL Therapeutics
Ontario Brain Institute
Opiant Pharmaceuticals
OPIS
Oppenheimer & Co.
Opto Capital Group
Opus Biotech Communications
Oracle Partners
Oragenics
Oramed Pharmaceuticals
Orange Grove Bio
OrbiMed Advisors
Orchard View Capital Advisors
Orgenesis
OriCiro Genomics
Origenis Gmbh
Oryzon Genomics
Otsuka Pharmaceutical Co.
Outlook Therapeutics
Ovid Therapeutics
Oxford Finance
Oxidien Pharmaceuticals
OxStem Limited
Pacific Western Bank
PainQx
Panorama Medicine
Pappas Capital
Paras Biopharmaceuticals Finland Oy
Paratek Pharmaceuticals
Park Ave. Capital Management International
Parkman Healthcare Partners
Parkville Advisors
Pattern Pharma
PDS Biotechnology
Peak One Investments
Perseverance Capital Advisors
Petrichor Healthcare Capital Management
Pfizer
PhagoMed Biopharma GmbH
Phanes Therapeutics
Pharma Intelligence
PharmaDirections
Pharmakon Advisors
PHD Biosciences
Phosplatin Therapeutics
Pipeline Therapeutics
Piper Sandler
POINT Biopharma
Polynoma
POP Biotechnologies
Portola Capital Parnters
Praetego
Premier Partners
Prevail Partners
Princeton Biopharma
Principia Biopharma
Prism Biomedical Research
Proactive Investors
Proactiveinvestors North America
Promethean Capital Group
ProMIS Neurosciences
Protalix Biotherapeutics
Qrono
Quadrant Biosciences
Quan Capital
RallyBio
Rapafusyn Pharmaceuticals
Raymond James & Associates
RBI
RBW Consulting
RDMD
Red Hook Asset Management
Redx Pharma
ReForm Biologics
Regals Capital
Remsen Investors
Rescue Hearing
Revach Fund
Rezolute
RG+A
RHK Capital
RHO
Ripple Therapeutics
RMJ Holdings
Robert W. Baird & Co.
Rockwell Medical
Roher/Sprague Partners
Roivant Sciences
Rolin
Rosetta Capital
Roth Capital Partners
RubrYc Therapeutics
Rumble Ventures
Rumi Scientific California
Russo Partners
RW Baird
Safi Biosolutions
Sagard Holdings
Salarius Pharmaceuticals
Samus Therapeutics
Sandhill Angels
Sandoz
Sanofi US
Santen Pharmaceutical Co.
Sarissa Capital Management
Satter Medical Technology Partnership
SBI JI Innovation Fund
Scancell
Scynexis
SDIC Fund Management
Second Line Capital Management
Sector Asset Management
Selexis
Semper8 Capital
Seneca Biopharma
Sengenics
SEngine Precision Medicine
Serimmune
Serrado Capital
Servier
Shanghai Henlius Biotech
ShareVault
Shaw Strategic Capital
Shawn Tomasello Consulting
Shinkei Therapeutics
Sichel Therapeutics
SidekickHealth
Sigma Principal Capital
Signature Bank
Silk Road Therapeutics
Simcere Pharmaceutical Group
Simrx Advisors
Sio Capital Management
Sky Ventures Group
Slater Technology Fund
SmartPharm Therapeutics
Smilegate Investment
SMP Communications
Sofinnova Ventures
Solar Capital Partners
Soligenix
Sound Affects
Sparrow Pharmaceuticals
Special Situations Funds
SPRIM Ventures
SR One
SRH Holding
Stalicla
Starlink Capital
Stemsynergy Therapeutics
Step Pharma
Sterling Bay
SternAegis Ventures
Sternberg Investments
Stonehenge Capital
Stran Capital
Strathspey Crown
STRH
Summit Therapeutics
Sun Pharmaceuticals
Sunforest Capital
SunTrust Bank
SunTrust Robinson Humphrey
Surveyor Capital
Sutro Biopharma
Sutton Place Capital Management
SVB Leerink
Swiss Business Hub USA
SynDevRx
Syneos Health
Synlogic
Synthetic Biologics
Synthis
Syzygy Therapeutics
Taiho Ventures
Tang Capital Management
TargetGene Biotechnologies
Tectonic Capital
Teon Therapeutics
Terra Stone Capital
Terran Biosciences
Tetra Therapeutics
TFF Pharmaceuticals
The Abraham Group
The Anson Group
The Astrologers Fund
The Benchmark Company
The Center for Performance Investing
The Engine
The Leukemia & Lymphoma Society
The Lind Partners
The Money Channel
TheraTarget
Think Equity
Thoth Science
Tiberend Strategic Advisors
TnA Therapeutics
Tokyo Stock Exchange
TONIX Pharmaceuticals
Torreya
Tosoh USA
TransPacific Venture Capital Partners
Treehill Principal Strategies
Trevena
TrialSpark
Tri-Medix
TriSalus Life Sciences
Trovagene
Tryphon Capital Advisors
Tulane University
TVAX Biomedical
twoXAR
University of California, San Diego
United Mitochondrial Disease Foundation
University of Birmingham
University of Exeter
University of Notre Dame
Unterberg Capital
Upstream Partners
V2m Life Sciences Fund
ValQuest
Varana Capital
Vaximm
VBL Therapeutics
Vector Capital
Vector Point Ventures
Vector Resource Funds
VenatoRx Pharmaceuticals
Venture Valuation
VerImmune
Verum Diagnostics
Vida Strategic Partners
viDA Therapeutics
Vida Ventures
Vigeo Therapeutics
Viking Therapeutics
Vincere Biosciences
Viracta Therapeutics
Vista Capital Advisors
Vista Point Capital
Vita Therapeutics
Vivo Capital
Voya Financial
VWR International
VWR, part of Avantor
Vyome Therapeutics
W Global Capital
Wallachbeth Capital
WBB Securities
Western International
Westlake Ventures
Westwood Therapeutics
Wexford Capital
Wick Capital Partners
Wolpert Associates
Women In Bio
X-Biotix Therapeutics
Xeraya Capital Life Venture
Xerion Investments
XyloCor Therapeutics
YA Global
Yale University, Office of Cooperative Research
Yamo Pharmaceuticals
YlLGA Management Services
Young America Capital
Zacks Small Cap Research
Zeniths Capital
Zikani Therapeutics
ZJ Future
Zymeworks

*As of 2/7/2020